Mutual Help Alternatives for Alcohol Problems: Benefits and Causal Mechanisms
酒精问题的互助替代方案:好处和因果机制
基本信息
- 批准号:10627918
- 负责人:
- 金额:$ 36.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdultAffectAlcohol abuseAlcoholics AnonymousAlcoholsAmendmentBehaviorClinicalClinical TrialsCognitionCollaborationsComparative StudyContinuity of Patient CareCoping SkillsDataDrug usageEffectivenessFundingGrowthHealthIndividualInfluentialsInterventionLongitudinal StudiesMeasuresMediationMediatorMinority GroupsModelingMotivationNational Institute on Alcohol Abuse and AlcoholismNatureOutcomeParticipantPatientsPersonsPharmaceutical PreparationsPlanning TheoryPopulationProcessProtocols documentationProviderPublishingQuality of lifeRecoveryRecovery SupportRegulationReligionResearchResourcesRightsSamplingSelf EfficacySeveritiesSpiritualityStress and CopingSubstance Use DisorderSurveysTargeted ResearchTestingTimeWomanaddictionalcohol use disorderbehavior changecohesioncomparative efficacycourtdesignimprovedindividualized medicineinnovationmeetingsmembermodel designmortalitynovelonline resourcepeer networkssatisfactionsobrietysocial engagementsubstance usesupport networksustained recoverytheoriestreatment planningvirtual
项目摘要
ABSTRACT
Rationale: Mutual help groups represent an important and unique resource on the recovery care continuum,
and Alcoholics Anonymous and other 12-step groups have been well-studied and found to be highly effective.
Yet, very little is known about the nature and effectiveness of mutual help alternatives for addiction. This is a
critical gap because 12-step groups remain unappealing for most people with substance use disorders (SUDs),
even following 12-step facilitation interventions, and because those deterred by 12-step groups may be attracted
to alternatives. Understanding 12-step alternatives is also important because a sizeable minority of people with
SUDs are mandated to treatment, and numerous higher courts have ruled that mandating 12-step attendance
violates First Amendment rights, stipulating that mandated attendance is permissable only given secular options.
Accordingly, the current R01 proposes a national, longitudinal study of the largest known secular, abstinence-
based alternatives to 12-step groups: Women for Sobriety (WFS), LifeRing Secular Recovery (LifeRing), and
SMART Recovery (SMART). Approach: Our NIAAA-funded R21 was the first longitudinal, comparative study
of 12-step groups and 12-step alternatives, and surveyed U.S. adults with lifetime alcohol use disorders attending
WFS, LifeRing, SMART, and 12-step groups. This R01 will capitalize on and extend our R21 data by adding
800 new cases collected using parallel protocols and measures, permitting us to combine data. Data will be
collected at baseline via collaboration with mutual help group directors and IntheRooms, an online meeting hub
for those in recovery. Follow-ups will be collected at 6 and 12 months. Leveraging these well-powered data, we
will 1) examine associations between both in-person and online involvement and substance use outcomes over
time. We incorporate study of online involvement because extremely little is known on this topic, and because
online resources have great potential where meeting access is limited. We will also 2) compare mechanisms of
action across mutual help groups, testing a novel theory of behavior change—the Affect, Cognition, Motivation,
and social Engagement in recovery (ACME) model—designed to predict sustained recovery. Tests will help
determine whether 12-step alternatives have common or distinct mechanisms of action, and will inform
interventions for SUDs broadly. Finally, we will 3) examine participant-level moderators of the benefits of mutual
help involvement, informing treatment tailoring. In anticipation of this R01, R21 surveys included most key
measures. Innovation and Significance: Evidence on 12-step alternatives is severely lacking: Other than our
team’s R21, there are no published longitudinal, comparative studies of 12-step groups and secular alternatives.
Results of this study, led by experts in mutual help groups for addiction, will contribute substantially to
understanding whether, when, and why mutual help alternatives are effective. Findings should inform court
referrals and treatment planning, and may enhance the growth of effective alternatives. Results may also help
to identify core drivers of recovery that can be targeted in diverse interventions for SUDs.
摘要
理由:互助小组是康复护理连续体的一个重要和独特的资源,
匿名戒酒会和其他12步小组已经得到了很好的研究,并发现非常有效。
然而,很少有人知道的性质和有效性的互助替代成瘾。这是一
关键的差距,因为12步组仍然没有吸引力的大多数人与物质使用障碍(SUD),
即使在12步促进干预之后,因为那些被12步小组阻止的人可能会被吸引
到替代品。理解12步替代方案也很重要,因为相当多的少数人
SUD被要求接受治疗,许多高等法院已经裁定,强制12步出勤
违反了第一修正案的权利,规定强制出席是允许的,只有给予世俗的选择。
因此,目前的R 01提出了一个全国性的,纵向研究的最大已知的世俗,禁欲-
12步组的替代方案:妇女清醒(WFS),生命环世俗恢复(生命环),
智能恢复(SMART)。方法:我们的NIAAA资助的R21是第一个纵向比较研究。
12步组和12步替代方案,并调查了美国成年人与终身酒精使用障碍参加
WFS、LifeRing、SMART和12步组。此R 01将利用和扩展我们的R21数据,
800个新病例使用并行协议和措施收集,使我们能够联合收割机数据。数据将
通过与互助小组主管和IntheRooms(一个在线会议中心)合作,在基线时收集
对于那些在恢复。将在6个月和12个月时收集随访数据。利用这些强大的数据,我们
将1)检查面对面和在线参与与物质使用结果之间的关联,
时间我们纳入在线参与的研究,因为对这个主题知之甚少,
在会议机会有限的情况下,在线资源具有很大的潜力。我们还将2)比较
行动在互助组,测试一种新的理论的行为改变的影响,认知,动机,
和社会参与恢复(ACME)模型,旨在预测持续的恢复。测试将帮助
确定12步替代方案是否具有共同或独特的作用机制,并将告知
广泛地干预SUD。最后,我们将3)检查参与者级别的主持人的利益,
帮助参与,提供治疗定制信息。在R 01的预期中,R21调查包括了大多数关键的
措施创新和意义:12步替代方案的证据严重缺乏:除了我们的
研究团队的R21,没有发表的纵向,比较研究的12步组和世俗的替代品。
这项由成瘾互助小组专家领导的研究结果将大大有助于
了解互助方案是否、何时以及为什么有效。调查结果应告知法院
转诊和治疗规划,并可能促进有效替代品的增长。结果也可能有所帮助
确定可在针对SUD的各种干预措施中针对的恢复的核心驱动因素。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Predictors and outcomes of online mutual-help group attendance in a national survey study.
- DOI:10.1016/j.jsat.2022.108732
- 发表时间:2022-07
- 期刊:
- 影响因子:3.9
- 作者:Timko, Christine;Mericle, Amy;Kaskutas, Lee Ann;Martinez, Priscilla;Zemore, Sarah E.
- 通讯作者:Zemore, Sarah E.
Understanding the social and community support experiences of sexual and gender minority individuals in 12-Step programs.
了解 12 步计划中性少数群体和性别少数群体的社会和社区支持经历。
- DOI:10.1080/10538720.2023.2172759
- 发表时间:2023
- 期刊:
- 影响因子:1.5
- 作者:McGeough,BrianaL;Paceley,Meg;Zemore,SarahE;Lunn,MitchellR;Obedin-Maliver,Juno;Lubensky,MicahE;Flentje,Annesa
- 通讯作者:Flentje,Annesa
Maintaining recovery from alcohol use disorder during the COVID-19 pandemic: The importance of recovery capital.
- DOI:10.1016/j.drugalcdep.2021.109142
- 发表时间:2021-12-01
- 期刊:
- 影响因子:4.2
- 作者:Gilbert PA;Soweid L;Kersten SK;Brown G;Zemore SE;Mulia N;Skinstad AH
- 通讯作者:Skinstad AH
Improving assessment of alcohol treatment barriers among Latino and White adults with an alcohol use disorder: Development of the barriers to specialty alcohol treatment scale.
改善对患有酒精使用障碍的拉丁裔和白人成年人的酒精治疗障碍的评估:制定专业酒精治疗障碍量表。
- DOI:10.1016/j.drugalcdep.2023.109895
- 发表时间:2023
- 期刊:
- 影响因子:4.2
- 作者:Pinedo,M;Castro,Y;Gilbert,PA;Caetano,R;Zemore,SE
- 通讯作者:Zemore,SE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH E. ZEMORE其他文献
SARAH E. ZEMORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH E. ZEMORE', 18)}}的其他基金
Mutual Help Alternatives for Alcohol Problems: Benefits and Causal Mechanisms
酒精问题的互助替代方案:好处和因果机制
- 批准号:
10413241 - 财政年份:2020
- 资助金额:
$ 36.05万 - 项目类别:
Mutual Help Alternatives for Alcohol Problems: Benefits and Causal Mechanisms
酒精问题的互助替代方案:好处和因果机制
- 批准号:
10249057 - 财政年份:2020
- 资助金额:
$ 36.05万 - 项目类别:
12-step Alternatives and Recovery Outcomes in a Large National Study
大型全国性研究中的 12 步替代方案和恢复结果
- 批准号:
8924892 - 财政年份:2014
- 资助金额:
$ 36.05万 - 项目类别:
12-step Alternatives and Recovery Outcomes in a Large National Study
大型全国性研究中的 12 步替代方案和恢复结果
- 批准号:
8787902 - 财政年份:2014
- 资助金额:
$ 36.05万 - 项目类别:
Hotspots: Understanding Areas of Concentrated Alcohol and Drug Problems at the US-Mexico Border
热点:了解美墨边境酒精和毒品问题集中的地区
- 批准号:
9228313 - 财政年份:
- 资助金额:
$ 36.05万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.05万 - 项目类别:
Research Grant














{{item.name}}会员




